U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 11 - 12 of 12 results

Lacticaseibacillus rhamnosus

MORE DETAILS

9601IVB87J

structurally diverse
Status:
Possibly Marketed Outside US
Source:
21 CFR 346
(2023)
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ddb64449-c524-4776-83f0-f98b45d0de59
First approved in 2015
Source:
21 CFR 352
Source URL:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=20f97683-05e2-4202-e054-00144ff88e88
Class:
STRUCTURALLY DIVERSE

Lacticaseibacillus rhamnosus GG

MORE DETAILS

4VNZ1M3QXY

structurally diverse
Status:
Possibly Marketed Outside US
Source:
Canada:LACTOBACILLUS RHAMNOSUS
Source URL:
https://tripod.nih.gov/npc/#Download
Class:
STRUCTURALLY DIVERSE

Showing 11 - 12 of 12 results

NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966